Holocarboxylase synthetase deficiency

Revision as of 16:01, 9 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Holocarboxylase synthetase deficiency
OMIM 253270
DiseasesDB 32709
eMedicine ped/1020 
MeSH D028922

WikiDoc Resources for Holocarboxylase synthetase deficiency

Articles

Most recent articles on Holocarboxylase synthetase deficiency

Most cited articles on Holocarboxylase synthetase deficiency

Review articles on Holocarboxylase synthetase deficiency

Articles on Holocarboxylase synthetase deficiency in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Holocarboxylase synthetase deficiency

Images of Holocarboxylase synthetase deficiency

Photos of Holocarboxylase synthetase deficiency

Podcasts & MP3s on Holocarboxylase synthetase deficiency

Videos on Holocarboxylase synthetase deficiency

Evidence Based Medicine

Cochrane Collaboration on Holocarboxylase synthetase deficiency

Bandolier on Holocarboxylase synthetase deficiency

TRIP on Holocarboxylase synthetase deficiency

Clinical Trials

Ongoing Trials on Holocarboxylase synthetase deficiency at Clinical Trials.gov

Trial results on Holocarboxylase synthetase deficiency

Clinical Trials on Holocarboxylase synthetase deficiency at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Holocarboxylase synthetase deficiency

NICE Guidance on Holocarboxylase synthetase deficiency

NHS PRODIGY Guidance

FDA on Holocarboxylase synthetase deficiency

CDC on Holocarboxylase synthetase deficiency

Books

Books on Holocarboxylase synthetase deficiency

News

Holocarboxylase synthetase deficiency in the news

Be alerted to news on Holocarboxylase synthetase deficiency

News trends on Holocarboxylase synthetase deficiency

Commentary

Blogs on Holocarboxylase synthetase deficiency

Definitions

Definitions of Holocarboxylase synthetase deficiency

Patient Resources / Community

Patient resources on Holocarboxylase synthetase deficiency

Discussion groups on Holocarboxylase synthetase deficiency

Patient Handouts on Holocarboxylase synthetase deficiency

Directions to Hospitals Treating Holocarboxylase synthetase deficiency

Risk calculators and risk factors for Holocarboxylase synthetase deficiency

Healthcare Provider Resources

Symptoms of Holocarboxylase synthetase deficiency

Causes & Risk Factors for Holocarboxylase synthetase deficiency

Diagnostic studies for Holocarboxylase synthetase deficiency

Treatment of Holocarboxylase synthetase deficiency

Continuing Medical Education (CME)

CME Programs on Holocarboxylase synthetase deficiency

International

Holocarboxylase synthetase deficiency en Espanol

Holocarboxylase synthetase deficiency en Francais

Business

Holocarboxylase synthetase deficiency in the Marketplace

Patents on Holocarboxylase synthetase deficiency

Experimental / Informatics

List of terms related to Holocarboxylase synthetase deficiency

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Holocarboxylase synthetase deficiency is an inherited disorder in which the body is unable to use the vitamin biotin effectively. This disorder is classified as a multiple carboxylase deficiency, a group of disorders characterized by impaired activity of certain enzymes that depend on biotin. The signs and symptoms of holocarboxylase synthetase deficiency typically appear within the first few months of life, but the age of onset varies. Affected infants often have immunodeficiency diseases, difficulty feeding, breathing problems, a skin rash, hair loss (alopecia), and a lack of energy (lethargy). Immediate treatment and lifelong management (using biotin supplements) may prevent many of these complications. If left untreated, the disorder can lead to delayed development, seizures, and coma. These medical problems may be life-threatening in some cases.

This condition is inherited in an autosomal recessive pattern, which means two copies of the gene in each cell are altered.

Mutations in the HLCS gene cause holocarboxylase synthetase deficiency. The HLCS gene makes an enzyme, holocarboxylase synthetase, that attaches biotin to other molecules. Biotin, a B vitamin, is found in foods such as liver, egg yolks, and milk. It is essential for the normal production and breakdown of proteins, fats, and carbohydrates in the body. Mutations in the HLCS gene reduce the activity of holocarboxylase synthetase, preventing cells from using biotin effectively and disrupting many cellular functions. These defects lead to the serious medical problems associated with holocarboxylase deficiency.

This article incorporates public domain text from The U.S. National Library of Medicine

Template:WH Template:WikiDoc Sources